Research Paper Volume 14, Issue 15 pp 6316—6337
SAAL1, a novel oncogene, is associated with prognosis and immunotherapy in multiple types of cancer
Figure 11. Analysis of SAAL1 drug sensitivity. The expression of SAAL1 was associated with the sensitivity of chelerythrine, PX-316, nelarabine, AT-13387, ifosfamide, vorinostat, belinostat, obatoclax, everolimus, benzylguanine, LY-294002, rapamycin, 5-fluoro deoxyuridine, paclitaxel, cisplatin, olaparib, and denileukin diftitox (Ontak). Cor, correlation coefficient.